Prognostic & predictive Test for Liver cancer
A prognostic and predictive combined test to predict the 5-year survival as well as the efficacy of treatment for liver cancer patients. The test can
- Significantly reduce the expense of diagnostic test by one-stop service
- Support the determination of treatment (surgery / Nexevar®)
The service is expected to be launched in the second half of 2020.